• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    BMP Medical Expands Sterling, Massachusetts Facility

    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy

    Environmental Sustainability Becoming Increasingly Important to Medtech Industry

    Duane DiFranco Joins Harvard MedTech’s Medical Advisory Board

    Lionel Bonte Named President of Mativ’s Healthcare and Wellness Business Unit
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Paragon Medical

    LEMO USA Inc.

    Providence Enterprise USA Inc.

    NDH Medical Inc.

    Fusion Biotec Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Paragon Medical

    LEMO USA Inc.

    Providence Enterprise USA Inc.

    NDH Medical Inc.

    Fusion Biotec Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    The Evolution of Chemical Characterization for Medical Devices

    Evaluation of biological safety of devices is experiencing some of the most significant changes in history.

    Related CONTENT
    • Providien
    • Zeus
    • Laboratory Testing Inc.
    • JK Medirise-Disposable Medical Device Company
    • WuXi AppTec Medical Device Testing
    Sandi Schaible, Senior Director, Analytical Chemistry and Regulatory Toxicology, WuXi AppTec Medical Device Testing04.01.21
    In recent years, medical device manufacturers have faced rapidly evolving expectations about conducting biocompatibility testing to support preclinical product safety testing. With the recent changes to ISO 10993, the evaluation of biological safety of devices is experiencing some of the most significant changes in history.

    Regulators quickly adopted the publication of ISO 10993-1:2018 (Part 1) because it requires manufacturers to develop biological test strategies based on their devices' potential risks. With this new guidance, physical and chemical information should be the starting point for identifying device-specific risks.

    Additionally, the number of devices that fall within reach of ISO 10993-1 and corresponding guidance documents has rapidly expanded. Teams still familiarizing themselves with these evaluation processes and regulatory expectations should take the time to understand the history of the methods at hand, the thought process that has advanced it, and how to apply this historical lens moving forward.

    The Debut of Chemical Characterization
    Manufacturers became accustomed to conducting a more standardized set of tests based on their device's contact type and duration before the revised ISO 10993-1 was released in 2018. Testing strategies specific to the device were not common, and oftentimes, the testing that could reveal unknown risks, such as the chemical characterization and risk assessment, was the final task left before product approval submission. This approach could, at times, leave manufacturers scrambling at the last moment to mitigate unanticipated risks.

    During this period of time, the shift to identifying potentially harmful compounds earlier in the process was gaining traction with regulatory bodies. With the pathway to submission leaving little room for error, this new mindset often left sponsors with concerns they may not have planned to address.

    The U.S. Food and Drug Administration (FDA) created a launchpad for revising the standard through its 2016 Draft Guidance on the Use of ISO 10993 Part 1. The guidance outlined the role of chemical characterization in the process and the importance of addressing it first. This FDA guidance played an instrumental role in revising ISO 10993-1, which formalized chemical characterization and the subsequent risk assessment as a fundamental requirement in assessing a device's safety.

    Chemical characterization can take many forms, from a paper-based review of all materials to a targeted study focusing on one compound of concern. Most frequently, it requires an extractables study consisting of exaggerated extraction of the device, followed by an analysis of the chemical constituents using a range of analytical methods.

    In the early days, high-risk devices were typically the products that required chemical characterization. Slowly, chemistry became a requirement for other devices, including permanent implants, prolonged contacting devices, and devices in contact with circulating blood.

    The revised version of ISO 10993-1 was released in 2018 and created a new standard that prioritized chemical characterization in evaluating a medical device's biological safety. This standard continued to drive the shift in regulatory expectations and the changing approach to determining biocompatibility endpoints. As reviewers became savvier from a technical standpoint, they began to ask more questions and required manufacturers justify their scientific approach to chemical characterization.

    The Evolution of Testing Methods
    As testing evolved, regulators supported the refinement of acceptable testing plans to include chemical characterization. These analytically selective and sensitive methods began to prove their value as the industry shifted from a checklist approach to a more strategic method of biological safety testing. Over time, the requirements for conducting chemistry testing have improved and become more rigorous.

    One example of the evolving testing requirements is how the number of solvents applied by laboratories has increased in addition to the aggressiveness of the extractions themselves. The pendulum continued to swing, applying exhaustive extraction techniques to both prolonged and permanent devices. This change pushed a growing portion of the market to new lengths, which led to extended testing timelines and increasing costs.

    Identifying the compounds detected in chemical characterization studies was no longer nice-to-have information but mandatory for the risk assessment process. A more robust understanding of chemicals present allowed for improved risk assessments. Effectively interpreting this data often requires a collaborative team that is in tune with how each regulatory body interprets the guidance at the given moment.

    The publication of ISO 10993-18:2020 introduces the analytical evaluation threshold (AET), which is the conversion from a dose-based threshold used by toxicologists to a concentration-based threshold used by chemists. The AET requires a partnership between the chemist and the toxicologist who will perform the risk assessment. Together they use inputs including the frequency and duration of the medical device’s clinical use, the extraction information used in the laboratory, and the uncertainty of the analytical method(s) to determine a level for which compounds detected in the chemistry study need to be identified. Not only does it create a “common language” between two integral parts of the evaluation process, but it levels the playing field of what manufacturers should expect from their laboratory testing partners.

    Regulators are gradually implementing enhanced material identification expectations across the board and driving the importance of advanced chemical characterization. This is evident by the release of the FDA guidance, Use of International Standard ISO 10993-1, “Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process.” Manufacturers must be on their toes to keep up and consistently assess their compliance with the latest requirements.

    Continued Evolution, Continued Investments
    In a perpetual effort to better understand the chemical risks of devices entering the market, the industry continues to establish more consistent and thorough evaluation procedures that better recognize the risks associated with each device.

    The different chemical characterization methods are ever-evolving, and regulators expect more information from these studies, including a justification of the approach (i.e., choice of solvents, analytical method, and extraction conditions). To keep up with this process, manufacturers should maintain current records that include regulators' current expectations. Legacy products and those with testing procedures dated from even just a few years ago may have a lot of catching up to do.

    For many products, testing completed before the release of ISO 10993-18:2020 is likely obsolete with the current chemical characterization studies' expectations. Managing a range of products in this environment can be an arduous process during the transition, but the efforts will benefit patients in the long run.

    Looking Forward
    The medical device industry is always working toward ensuring patient safety remains the top priority, and the methods for supporting safety through testing will continue to evolve. Manufacturers should understand the latest requirements and be prepared to invest in a quality chemical characterization study to ensure a solid foundation for the rest of their program. In fact, in the next year or so, an updated ISO 10993-17 guidance document will provide manufacturers additional information on performing toxicological risk assessments of these chemical constituents.

    Medical device companies are responsible for evaluating their product’s safety before entering the market, but it is not a challenge they should face alone. Leaning on industry partners involved in the regulatory landscape can help companies stay relevant and competitive by maintaining the most up-to-date technical files. More information on regulatory expectations and some additional tips on preparing for regulatory requests and minimizing impact can be found at bit.ly/3qRiTFD. 


    Sandi Schaible is the senior director of analytical chemistry and regulatory toxicology at St. Paul, Minn.-based WuXi AppTec Medical Device Testing, which specializes in extractables and leachables studies. She is a U.S. delegate and international delegate for ISO 10993 part 18 in chemical characterization, and also a U.S. delegate for ISO 10993 part 13 and the particulates committee (TIR42).
    Related Searches
    • Testing
    Related Knowledge Center
    • Testing
    Suggested For You
    Providien Providien
    Zeus Zeus
    Laboratory Testing Inc. Laboratory Testing Inc.
    JK Medirise-Disposable Medical Device Company JK Medirise-Disposable Medical Device Company
    WuXi AppTec Medical Device Testing WuXi AppTec Medical Device Testing
    DDL Inc. DDL Inc.
    sfm medical devices GmbH sfm medical devices GmbH
    Hangsterfer Hangsterfer's Laboratories
    Anjon Medical Technologies Anjon Medical Technologies
    IMA Automation North America IMA Automation North America
    Auriga Inc. Auriga Inc.
    WESTPAK Inc. WESTPAK Inc.
    BMP Medical - Delivering Custom Plastics Manufactured Solutions BMP Medical - Delivering Custom Plastics Manufactured Solutions
    High Tech Turning Co. Inc. High Tech Turning Co. Inc.
    Breakthrough Device Designation Granted for New Neuromodulation Platform Breakthrough Device Designation Granted for New Neuromodulation Platform

    Related Buyers Guide Companies

    • Providien

      Providien

      ...
      Bonalyn Boyd, Marketing Manager 11.30.22

    • Zeus

      Zeus

      ...
      Laura Bright, Ad Manager 11.18.22

    • Laboratory Testing Inc.

      ...
      Sharon Bentzley, Marketing Manager 11.17.22


    • JK Medirise-Disposable Medical Device Company

      ...
      Ketan Munjani, Marketing Manager 11.17.22

    • WuXi AppTec Medical Device Testing

      ...
      Tim Xi, Marketing Manager 11.11.22

    Loading, Please Wait..

    Trending
    • Study: Catheter Ablation Significantly Lowers Dementia Risk In AFib Patients
    • Abbott's Proclaim XR SCS OK'ed For Diabetic Neuropathy
    • BMP Medical Expands Sterling, Massachusetts Facility
    • Tandem Diabetes Completes Deal For AMF Medical
    • The Future Of Biomedical Engineering Advancements
    Breaking News
    • BMP Medical Expands Sterling, Massachusetts Facility
    • Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
    • Environmental Sustainability Becoming Increasingly Important to Medtech Industry
    • Duane DiFranco Joins Harvard MedTech’s Medical Advisory Board
    • Lionel Bonte Named President of Mativ’s Healthcare and Wellness Business Unit
    View Breaking News >
    CURRENT ISSUE

    November 2022

    • MPO's 2022 Year in Review
    • Fine Print: A Discourse on Additive Manufacturing
    • Grab and Go: Examining the Thrombectomy Device Market
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients
    Vitamin D Supplementation Reduces Risk of Dynapenia
    Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    Coatings World

    Latest Breaking News From Coatings World

    Epoxytec Announces New Website Launch
    Paints and Coatings Market Worth $212B by 2026: MarketsandMarkets
    Axalta Releases Fourth Quarter and Full Year 2022 Results
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    BMP Medical Expands Sterling, Massachusetts Facility
    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
    Environmental Sustainability Becoming Increasingly Important to Medtech Industry
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pasithea Signs CMC Development and Manufacturing Agreement
    Experic Expands Analytical Capabilities and Facilities
    List Labs Expands Manufacturing Capacity
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Haircare Brand Uncle Funky’s Daughter Announces Retail Expansion
    TRESemmé Introduces New Pro Infusion Collection
    Walgreens Boots Alliance Shares 2022 ESG Report
    Happi

    Latest Breaking News From Happi

    KimChi Beauty Launches Spinning Hearts Love 02 Ahead of Valentine’s Day
    Dark & Lovely Names Actress Meagan Good Brand Ambassador
    Natural Household Care Company Tru Earth Adds Dishwasher Detergent Tablets
    Ink World

    Latest Breaking News From Ink World

    Xerox Releases 4Q, Full-Year 2022 Results
    Electronics For Imaging Names Frank Pennisi as CEO
    Fiery to Separate from EFI, Remain Wholly-Owned by Siris
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    EFI appoints Frank Pennisi CEO, Fiery now an independent business
    Bobst boosts senior sales team with Keith Nagle
    Penmar Industries adds Screen Truepress Jet L350UV SAI digital press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Essity’s Sales Grow
    Thinx to Pay up to $5 million to Settle Class Action Suit
    Typar Highlighting New Building Innovations
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Launches the Mariner Deformity System
    Tyber Medical Hires 2 New Execs
    Miach Ortho Raises $40M in Series B Funding
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Smart Devices with Privacy Focus Have More Consumer Appeal
    Siman Group Partners with SML to Unlock Full Retail Potential with RFID
    Brewer Science Presents Optics Integration Solutions at SPIE Photonics West

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login